Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Feature article about Theralase on biotuesdays.com website

<< Previous

Bullboard Posts

Next >>

Comment by plantraderon Jan 03, 2023 4:05pm

223 Views

Post# 35201469

RE:Feature article about Theralase on biotuesdays.com website

If we take this purely at face value, it indicates they have to complete PII. Which means more time. But, it also indicates that things look SO GOOD at this point that they are expecting big pharma interest before PII is complete. Of course, we can infer and hope that it means BTD/AA will happen in the meantime. Really encouraging article!

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments